Pharmacokinetics of Staccato Loxapine for Inhalation in Smokers Compared to Nonsmokers.
Phase of Trial: Phase I
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Loxapine (Primary)
- Indications Agitation; Bipolar disorders; Migraine; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Alexza Pharmaceuticals
- 23 Jun 2009 Planned number of patients changed from 36 to 35 as reported by ClinicalTrials.gov.
- 23 Jun 2009 Status changed from recruiting to completed as reported byClinicalTrials.gov.
- 14 Apr 2009 New trial record